New Markers of Cardiac Surgery Related Acute Kidney Injury.

Pomeranian Medical University Szczecin88 enrolled

Overview

Cardiac surgery related acute kidney injury (CS-AKI) is a clinical problem associated with a cardiopulmonary bypass used during cardiac surgery procedures. In this study the investigators will assess the biochemical markers of acute kidney injury such as ischemia modified albumin (IMA) or urinary excreted of brush-border enzymes of the proximal renal tubules perioperatively. There has been no official recommendations toward routine use of analysed biomarkers.

Cardiac surgery related acute kidney injury (CS-AKI) is an important clinical problem. Kidney injury occurs following a cardiopulmonary bypass used during cardiac surgery procedures. The pathomechanisms of acute kidney injury (AKI) is complex and multifactorial. It may involve few injury pathways: ischemia and reperfusion, endogenous toxins, inflammation, metabolic factors and oxidative stress. Biochemical markers of acute kidney injury such as ischemia modified albumin (IMA) or urinary excreted of brush-border enzymes of the proximal renal tubules analysed perioperatively will be assessed in this study. There has been no official recommendations toward routine use of analysed biomarkers.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Acute Kidney Injury Cardiac Disease

Interventions

urine and blood analysisDIAGNOSTIC_TEST

concentration of ischemia modified albumin assessed in blood before operation, immediately and one hour after cardiopulmonary bypass, 24 hours after operation; concentration of urinary excretion of brush-border enzymes of the proximal renal tubules assessed before operation, immediately and one hour after cardiopulmonary bypass, 24 hours after operation, serum creatinine levels will be evaluated on the day of the operation and 24 h and 48 h postoperatively

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * a planned operation of coronary artery bypass grafting with the use of cardiopulmonary bypass Exclusion Criteria: * emergency operations or re-operations; * a known pathology of the urinary tract or renal failure; * chronic use of the following medications: iron, non-steroidal anti-inflammatory drugs (NSAIDs), immunosuppression, or steroids in the preoperative period; * polycythemia, porphyria or pathological hemoglobin species in anamnesis; * preoperative signs of hepatic failure; * active autoimmune or neoplastic diseases, active infection; * anticipated significant bleeding (anti-platelet agents), suggesting the use of blood-derived products during the operation and afterward * acute myocardial infarction after operation

Locations (1)

Pomeranian Medical University

Szczecin, Poland

Outcomes

Primary Outcomes

acute kidney injure after operation

acute kidney injure measured by creatinine concentration mg/dl

Time frame: up to 48 hours post operation

acute kidney injure after operation

acute kidney injure measured by urine output in ml

Time frame: up to 48 hours post operation

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.